Brief: Exicure Announces Issuance Of Two New U.S. Patents And A New Patent Allowance Covering Cavrotolimod Through 2034
21/12/2020 16:57
Dec 21 (Reuters) - Exicure Inc XCUR.O :
* EXICURE ANNOUNCES ISSUANCE OF TWO NEW U.S. PATENTS AND A
NEW
PATENT ALLOWANCE COVERING CAVROTOLIMOD THROUGH 2034
Source text for Eikon: ID:nBw6HFVsLa
Further company coverage: XCUR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exicure
See all newsBrief: Exicure Announces 1-For-5 Reverse Stock Split
U.S. STOCKS ON THE MOVE-MercadoLibre, DoorDash, Coinbase
Brief: Exicure Inc Says Received Nasdaq Delinquency Notice On Late Filing Of Its Form 10-K
Brief: Exicure And Bluejay Therapeutics Enter Into A Patent License Agreement To Develop Cavrotolimod For The Treatment Of Hepatitis
Brief: Exicure Says Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq